Recon: J&J reports lung cancer therapy significantly prolonged survival in study; Stryker to buy Inari Medical for $4.9B
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States